ACAAM has an opportunity for members to share their interest in joining the organization’s Anti-Racism/Diversity, Equity & Inclusion Committee for 2022.
This opportunity will allow you to work with several accomplished and returning committee members to develop, implement, integrate, and support strategies and activities to achieve priority goals related to anti-racism, diversity, and inclusion and to create an equitable and welcoming environment within ACAAM.
The American Society of Addiction Medicine (ASAM) will be hosting the 2022 Addiction Medicine Advocacy Conference on March 7-8, 2022. This is a two-day virtual advocacy event. On the first day, attendees will receive training from expert advocacy professionals on issues important to the practice of addiction medicine and hear from key policymakers. Then, attendees will participate in carefully planned virtual Capitol Hill meetings to advance an ambitious policy agenda designed to support addiction treatment professionals as they treat patients and save lives.
ACAAM is honored to be a national advocacy partner for this Conference – along with the American College of Medical Toxicology, and the American Osteopathic Academy of Addiction Medicine. We look forward to advancing addiction medicine together!
Update...
The deadline has now passed for applications to the Boston Children’s Hospital Virtual Rotation for addiction medicine fellows.
Even as the recruitment season for the 2022 academic year continues, Addiction Medicine fellowships are beginning to look toward the next application cycle. Two closely related themes top the agenda: getting the word out to potential candidates and improving the process for applicants and fellowships alike.
At the latest ACAAM Virtual Town Hall on November 18, program directors, faculty, and coordinators gathered to begin discussing next steps. The meeting came exactly one month after the offer period for 2022 positions opened for most fellowships participating in the Common Decision Date. The Common Date plan provided a 3-month window of “protected time” so applicants could fully explore their options and programs could complete interviews before offers started.
During the June 2021 Annual Meeting’s Fellows Lightning Round session, Shawn Cohen, MD, presented “Simplifying Buprenorphine Microinduction in the Outpatient Setting.” Dr. Cohen is a second-year fellow in the Yale Program in Addiction Medicine.
Dr. Cohen’s presentation defined microinduction, described how his team explains it to partners and patients, and provided a few resources that may be used to aid its explanation. These resources include a Tweetorial that can be found in the presentation slides.
In early November, ACAAM launched a brand-new member benefit—an online Career Center where employers can recruit qualified candidates and job seekers can find their next addiction medicine job opportunity!
For Employers
We encourage you to take advantage of this new member benefit and post your open positions on the ACAAM Career Center. If you are an ACAAM member, a posting for up to 90 days is only $100 (nonmembers pay $450). And for additional visibility, you can upgrade your posting to a featured listing for only $150 extra.
The ACAAM National Addiction Medicine Didactic Curriculum is a weekly, fellowship-run didactic experience for addiction medicine fellows and faculty. The curriculum sessions are now in their second year, having launched at the beginning of the 2020-2021 academic year. Each week, dozens of addiction medicine fellowship program faculty and fellows convene for live Zoom sessions and to hear an expert speak on different addiction medicine topics. The topics are mapped to the American Board of Preventive Medicine (ABPM) addiction medicine exam blueprint as well as the ACGME medical competencies. In addition to faculty and fellows, sessions are open to all health care professionals and trainees interested in expanding their education about treating and assessing patients with substance use disorders.
During the June 2021 Annual Meeting’s Fellows Lightning Round session, Nicholas Chien, MD presented “Expanding Addiction Medicine Education Beyond A Traditional Fellowship: Local and National Endeavors.” Dr. Chien is a 2021 graduate of Rush University Medical Center’s addiction medicine fellowship program.
Dr. Chien’s presentation highlights three educational endeavors that addiction medicine fellows can participate in throughout their fellowship. From online courses and webinars to cross-institutional collaborations, these local and national endeavors are what make the addiction medicine fellowship a platform for educational excellence.
With the offer period for 2022-23 fellowship positions now open, a number of fellowships are expected to continue taking applications on a rolling basis until they have filled. We will post a Recruitment Directory indicating which programs these are as soon as we receive updates from the fellowships later this week.
Fellowship candidates should be aware that 48-hour response deadlines will be the norm when the majority of programs begin making offers for 2022-23 positions on October 18 at 7:00 PM Eastern. Guidance for candidates and fellowships alike is available under the Fellowship Resource Center.
The first ACAAM Virtual Addiction Medicine Training Recruitment Fair was held September 14, with residents from around the country meeting addiction medicine fellowships and learning about the specialty from a panel of program directors.
Thirty-nine addiction medicine fellowships participated in the event, which featured virtual breakout “tables” where interested residents could visit with fellowships one-on-one.
When patients are treated appropriately by medical professionals trained in addiction medicine, we can save lives and improve treatment outcomes. With that goal in mind, National Addiction Treatment Week has been created to raise awareness about the critical gap between the number of patients who need addiction treatment and their access to qualified medical professionals trained to provide evidence-based, specialty treatment. It also highlights the urgent need for clinicians to enter the field of addiction medicine and expand the qualified workforce. We hope you will join the week and our efforts to close the treatment gap and save lives.
This year, Addiction Treatment Week will focus on encouraging the next generation of clinicians and providers to learn more about addiction, evidence-based treatment, and career paths in the field of addiction medicine. Physicians who are board-certified in addiction medicine and clinicians who treat addiction daily will share why they chose to treat addiction and inspire medical students, residents, and fellows to join them in learning more about evidence-based addiction treatment.
During the 2021 ACAAM Annual Meeting, the organization’s Anti-Racism/Diversity, Equity & Inclusion Committee presented a session titled "Moving Beyond Kneeling: Promoting an Anti-Racist and Racial Justice Framework within Academic Addiction Medicine Fellowships."
During the session, the committee discussed the prevalence of microaggressions, and provided three tools that can be used to help combat them as they occur. These examples were related to specific scenarios discussed during the session, whose Powerpoint slides can be downloaded here for context.
During the June 2021 Annual Meeting’s Fellows Lightning Round session, Bhavna Bali, MD, a 2021 graduate of the Interdisciplinary Addiction Medicine Fellowship at Penn State College of Medicine, shared her research titled Outpatient Buprenorphine Microinduction for Pain “A Safe Method to Transition High-Risk Patients.”
After reviewing the basics of microdosing buprenorphine, Dr. Bali’s presentation focused on a specific case where a high-risk patient on high-dose opioids was transitioned to suboxone for pain management. The patient in question had been diagnosed with Physiological Opioid Dependence with a high risk of developing Opioid Use Disorder.
The American College of Addiction Medicine (ACAAM) has established itself as the go-to resource and advocate for academic addiction medicine fellowship programs. Today the organization is excited to announce it has exceeded 30 fellowship program institutional members, with a total of 32 programs currently enrolled. The ACAAM membership program was launched in May 2021.
“We are ecstatic to see fellowship programs enrolling as members and unlocking access to valuable benefits and resources for the faculty and fellows in their programs,” says ACAAM Membership Committee Chair, Alex Walley, MD. “The more programs that join our ACAAM membership coalition, the stronger our voices will be as we continue to advocate for resources needed to expand a fellowship-trained addiction medicine workforce.”
Contact: Bruce Hammond, CAE
Executive Director
847-375-4814
[email protected]
Attributable to ACAAM President, Martha Wunsch, MD FAAP DFSAM:
Bethesda, Maryland – December 17, 2020 – The American College of Academic Addiction Medicine (ACAAM) today announced the appointment of Bruce E. Hammond, Jr., CAE, as Executive Director, effective January 1, 2021. Mr. Hammond will step into the new position following the long-planned end-of-year retirement of Kevin Kunz, MD MPH DFSAM, founding ACAAM President (2008) and Executive Vice President since 2013. ACAAM was formerly known as the ABAM Foundation and Addiction Medicine Foundation.
Mr. Hammond will work closely with the ACAAM Board of Directors and ACAAM Vice President for Medical and Academic Affairs Tim Brennan, MD MPH to help fulfill the organization’s mission. ACAAM’s mission is the development and comprehensive support of addiction medicine fellowship programs, faculty and fellows at academic medical institutions and treatment centers across the U.S. There are currently 81 addiction medicine fellowship programs recognized and accredited by the Accreditation Council for Graduate Medical Education (ACGME), with more programs in development.
